The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy

British Journal of Radiology

Volumn 87, Issue 1041, 2014, Pages

  Sancey, L ^a   Lux, F ^a   Kotb, S ^a   Roux, S ^b   Dufort, S ^c,d,e   Bianchi, A ^f   Cremillieux Y ^f   Fries, P ^g   Coll, J L ^d,e   Rodriguez Lafrasse, C ^h   Janier, M ^a   Dutreix, M ⁱ   Barberi Heyob, M ^j   Boschetti, F ^k   Denat, F ^l   Louis, C ^c   Porcel, E ^m   Lacombe, S ^m   Le Duc, G ⁿ   Deutsch, E ^d   Perfettini, J L ^d   Detappe, A ^o   Verry, C ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Berbeco, R ^o   Butterworth, K T ^q   McMahon, S J ^q   Prise, K M ^q   Perriat, P ^m   Tillement, O ^a   more..

^a UNIVERSITÉ LYON 1   (France)

^b Faculté des Sciences et des Techniques La Bouloie   (France)

^c Nano H SAS   (France)

^d INSERM   (France)

^e UNIV GRENOBLE ALPES   (France)

^f CNRS University Bordeaux Segalen   (France)

^g SAARLAND UNIVERSITY   (Germany)

^h CENTRE HOSPITALIER LYON SUD   (France)

ⁱ INSTITUT CURIE   (France)

^j CENTRE DE RECHERCHE EN AUTOMATIQUE DE NANCY   (France)

^k CheMatech   (France)

^l UNIVERSITÉ DE BOURGOGNE   (France)

^m CNRS   (France)

ⁿ EUROPEAN SYNCHROTRON RADIATION FACILITY   (France)

^o HARVARD MEDICAL SCHOOL   (United States)

^p CHU La Tronche and University   (France)

^q QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; GADOTERATE MEGLUMINE; GOLD NANOPARTICLE; RADIOSENSITIZING AGENT; CONTRAST MEDIUM; NANOPARTICLE; SILOXANE;

ATOM; AUGER ELECTRON SPECTROSCOPY; CANCER PATIENT; CANCER RADIOTHERAPY; CELL DAMAGE; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSION TENSOR IMAGING; DOSIMETRY; DRUG DISTRIBUTION; DRUG EFFICACY; HUMAN; IMAGE GUIDED RADIOTHERAPY; IN VITRO STUDY; NANOPROBE; NEUTRON CAPTURE THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; RADIATION ATTENUATION; RADIATION DOSE; RADIATION NECROSIS; RADIOSENSITIZATION; REVIEW; THEORETICAL MODEL; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; MOUSE; NEOPLASMS;

ANIMALS; CONTRAST MEDIA; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MODELS, THEORETICAL; NANOPARTICLES; NEOPLASMS; RADIATION-SENSITIZING AGENTS; SILOXANES;

EID: 84907486504     PISSN: 00071285     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr.20140134     Document Type: Review

References (59)

1. Kwatra D, Venugopal A, Anant S. Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer. Transl Cancer Res 2013; 2: 330-42.
2. McMahon SJ, Mendenhall MH, Jain S, Currell F. Radiotherapy in the presence of contrast agents: a general figure of merit and its application to gold nanoparticles. Phys Med Biol 2008; 53: 5635-51. doi: 10.1088/0031-9155/53/20/005
3. Butterworth KT, Wyer JA, Brennan-Fournet M, Latimer CJ, Shah MB, Currell FJ, et al. Variation of strand break yield for plasmid DNA irradiated with high-Z metal nanoparticles. Radiat Res 2008; 170: 381-7. doi: 10.1667/RR1320.1
4. Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 2004; 49: N309-15.
5. Butterworth KT, McMahon SJ, Taggart LE, Prise KM. Radiosensitization by gold nanoparticles: effective at megavoltage energies and potential role of oxidative stress. Transl Cancer Res 2013; 2: 279-89.
6. Kelkar SS, Reineke TM. Theranostics: combining imaging and therapy. Bioconjug Chem 2011; 22: 1879-903. doi: 10.1021/bc200151q
7. Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 2012; 41: 2971-3010. doi: 10.1039/c2cs15344k
8. Butterworth KT, McMahon SJ, Currell FJ, Prise KM. Physical basis and biological mechanisms of gold nanoparticle radiosensitization. Nanoscale 2012; 4: 4830-8.
9. Anzalone N, Essig M, Lee SK, Dörfler A, Ganslandt O, Combs SE, et al. Optimizing contrast-enhanced magnetic resonance imaging characterization of brain metastases: relevance to stereotactic radiosurgery. Neurosurgery 2013; 72: 691-701.
10. McDuff SG, Taich ZJ, Lawson JD, Sanghvi P, Wong ET, Barker FG 2nd, et al. Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases. J Neurol Neurosurg Psychiatry 2013; 84: 1384-91.
11. Padovani L, Muracciole X, Régis J. g knife radiosurgery of brain metastasis from breast cancer. Prog Neurol Surg 2012; 25: 156-62.
12. Robbins ME, Brunso-Bechtold JK, Peiffer AM, Tsien CI, Bailey JE, Marks LB. Imaging radiation-induced normal tissue injury. Radiat Res 2012; 177: 449-66.
13. Cerviño LI, Du J, Jiang SB. MRI-guided tumor tracking in lung cancer radiotherapy. Phys Med Biol 2011; 56: 3773-85.
14. Alvarado R, Booth JT, Bromley RM, Gustafsson HB. An investigation of image guidance dose for breast radiotherapy. J Appl Clin Med Phys 2013; 14: 4085.
15. Alderliesten T, Betgen A, Elkhuizen PH, van Vliet-Vroegindeweij C, Remeijer P. Estimation of heart-position variability in 3Dsurface-image-guided deep-inspiration breath-hold radiation therapy for left-sided breast cancer. Radiother Oncol 2013; 109: 442-7.
16. Sander L, Langkilde NC, Holmberg M, Carl J. MRI target delineation may reduce long-term toxicity after prostate radiotherapy. Acta Oncol 2014; 53: 809-14. doi: 10.3109/0284186X.2013.865077
17. Santhanam AP, Dou T, Neylon J, Min Y, Kupelian A, Sheng K, et al. Multi-scale, multi-modal image integration for imageguided clinical interventions in the head and neck anatomy. Stud Health Technol Inform 2013; 184: 380-6.
18. Coulter JA, Hyland WB, Nicol J, Currell FJ. Radiosensitising nanoparticles as novel cancer therapeutics-pipe dream or realistic prospect? Clin Oncol (R Coll Radiol) 2013; 25: 593-603. doi: 10.1016/j.clon.2013.06.011
19. Di Corato R, Gazeau F, Le Visage C, Fayol D,Levitz P, Lux F, et al. High-resolution cellular MRI: gadolinium and iron oxide nanoparticles for in-depth dual-cell imaging of engineered tissue constructs. ACS Nano 2013; 7: 7500-12. doi: 10.1021/nn401095p
20. Liu F, He X, Liu L, You H, Zhang H, Wang Z. Conjugation of NaGdF4 upconverting nanoparticles on silica nanospheres as contrast agents for multi-modality imaging. Biomaterials 2013; 34: 5218-25. doi: 10.1016/j.biomaterials.2013.03.058
21. Hou Y, Qiao R, Fang F, Wang X, Dong C, Liu K, et al. NaGdF4 nanoparticle-based molecular probes for magnetic resonance imaging of intraperitoneal tumor xenografts in vivo. ACS Nano 2013; 7: 330-8.
22. Rodriguez-Liviano S, Becerro AI, Alcántara D, Graz u V, de la Fuente JM, Ocaña M. Synthesis and properties of multifunctional tetragonal Eu: GdPO4 nanocubes for optical and magnetic resonance imaging applications. Inorg Chem 2013; 52: 647-54.
23. Kang X, Yang D, Ma P, Dai Y, Shang M, Geng D, et al. Fabrication of hollow and porousstructured GdVO4: Dy31 nanospheres as anticancer drug carrier and MRI contrast agent. Langmuir 2013; 29: 1286-94. doi: 10.1021/la304551y
24. Smith CE, Shkumatov A, Withers SG, Yang B, Glockner JF, Misra S, et al. A polymeric fastener can easily functionalize liposome surfaces with gadolinium for enhanced magnetic resonance imaging. ACS Nano 2013; 7: 9599-610. doi: 10.1021/nn4026228
25. Csajb ók E, Bányai L, Vander Elst L, Muller RN, Zhou W, Peters JA. Gadolinium(III)-loaded nanoparticulate zeolites as potential high-field MRI contrast agents: relationship between structure and relaxivity. Chemistry 2005; 11: 4799-807.
26. Xu Z, Li C, Ma P, Hou Z, Yang D, Kang X, et al. Facile synthesis of an up-conversionluminescent and mesoporous Gd2O3 : Er31 @nSiO2@mSiO2 nanocomposite as a drugcarrier. Nanoscale 2011; 3: 661-7.
27. Shen Y, Shao Y, He H, Tan Y, Tian X, Xie F, et al. Gadolinium(31)-doped mesoporous silica nanoparticles as a potential magnetic resonance tracer for monitoring the migration of stem cells in vivo. Int J Nanomedicine 2013; 8: 119-27. doi: 10.2147/IJN.S38213
28. Erogbogbo F, Chang CW, May JL, Liu L, Kumar R, Law WC, et al. Bioconjugation of luminescent silicon quantum dots to gadolinium ions for bioimaging applications. Nanoscale 2012; 4: 5483-9. doi: 10.1039/c2nr31002c
29. Zohdiaghdam R, Riyahi-Alam N, Moghimi HR, Haghgoo S, Alinaghi A, Azizian G, et al. Development of a novel lipidic nanoparticle probe using liposomal encapsulated Gd2O3-DEG for molecular MRI. J Microencapsul 2013; 30: 613-23.
30. Qin H, Zhou T, Yang S, Chen Q, Xing D. Gadolinium(III)-gold nanorods for MRI and photoacoustic imaging dual-modality detection of macrophages in atherosclerotic inflammation. Nanomedicine (Lond) 2013; 8: 1611-24. doi: 10.2217/nnm.12.168
31. Tian X, Shao Y, He H, Liu H, Shen Y, Huang W, et al. Nanoamplifiers synthesized from gadolinium and gold nanocomposites for magnetic resonance imaging. Nanoscale 2013; 5: 3322-9. doi: 10.1039/c3nr00170a
32. Miyawaki J, Matsumura S, Yuge R, Murakami T, Sato S, Tomida A, et al. Biodistribution and ultrastructural localization of singlewalled carbon nanohorns determined in vivo with embedded Gd2O3 labels. ACS Nano 2009; 3: 1399-406. doi: 10.1021/nn9004846
33. Jahanbakhsh R, Atyabi F, Shanehsazzadeh S, Sobhani Z, Adeli M, Dinarvand R. ModifiedGadonanotubes as a promising novel MRI contrasting agent. Daru 2013; 21: 53. doi:10.1186/2008-2231-21-53
34. Mignot A, Truillet C, Lux F, Sancey L, Louis C, Denat F, et al. A top-down synthesis routeto ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications. Chemistry 2013; 19: 6122-36.
35. Lux F, Mignot A, Mowat P, Louis C, Dufort S, Bernhard C, et al. Ultrasmall rigid particles asmultimodal probes for medical applications. Angew Chem Int Ed Engl 2011; 51: 12299-3303.
36. Young SW, Qing F, Harriman A, Sessler JL, Dow WC, Mody TD, et al. Gadolinium(III)texaphyrin: a tumour selective radiation sensitizer that is detectable by MRI. Proc NatlAcad Sci U S A 1996; 93: 6610-5. Erratum in: Proc Natl Acad Sci U S A 1999; 96: 2569.
37. Dehnad H, Kal HB, Stam T, Gademan IS, van Moorselaar RJ, van der Sanden BP. Responseto motexafin gadolinium and ionizing radiation of experimental rat prostate and lungtumors. Int J Radiat Oncol Biol Phys 2003; 57: 787-93.
38. Francis D, Richards GM, Forouzannia A,Mehta MP, Khuntia D. Motexafin gadolinium:a novel radiosensitizer for brain tumors. Expert Opin Pharmacother 2009; 10: 2171-80.
39. Magda D, Lepp C, Gerasimchuk N, Lee I, Sessler JL, Lin A, et al. Redox cycling bymotexafin gadolinium enhances cellular response to ionizing radiation by forming reactive oxygen species. Int J Radiat Oncol Biol Phys 2001; 51: 1025-36.
40. Franken NA, Bergs JW, Kok TT, Kuperus RR, Stecher-Rasmussen F, Haveman J, et al. Gadolinium enhances the sensitivity of SW-1573 cells for thermal neutron irradiation. Oncol Rep 2006; 15: 715-20.
41. Shikata F, Tokumitsu H, Ichikawa H, Fukumori Y. In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer. Eur J Pharm Biopharm 2002; 53: 57-63.
42. Tokumitsu H, Hiratsuka J, Sakurai Y, Kobayashi T, Ichikawa H, Fukumori Y. Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor. Cancer Lett 2000; 150: 177-82.
43. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, et al. Renal clearance ofquantum dots. Nat Biotechnol 2007; 25: 1165-70. doi: 10.1038/nbt1340
44. Le Duc G, Miladi I, Alric C, Mowat P, Bräuer-Krisch E, Bouchet A, et al. Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles. ACS Nano 2011; 5: 9566-74.
45. Miladi I, Duc GL, Kryza D, Berniard A, Mowat P, Roux S, et al. Biodistribution of ultra small gadolinium-based nanoparticles as theranostic agent: application to brain tumors. J Biomater Appl 2013; 28: 385-94.
46. Bianchi A, Lux F, Tillement O, Crémillieux Y. High resolution contrast enhanced lung MRI in mice using ultra-short echo time radial imaging and intratracheally administrated Gd-based contrast agent. Magn Reson Med 2013; 70: 1419-26.
47. Bianchi A, Dufort S, Lux F, Courtois A, Tillement O, Coll JL, et al. Quantitative biodistribution and pharmacokinetics of multimodal gadolinium-based nanoparticles for lungs using ultrashort TE MRI. MAGMA October 2013. Epub ahead of print. doi: 10.1007/s10334-013-0412-5
48. Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem 2010; 21: 797-802.
49. Bianchi A, Dufort S, Lux F, Fortin PY, Tassali N, Tillement O, et al. Targeting and in vivo imaging of non-small-cell lung cancer using nebulized multimodal contrast agents. Proc Natl Acad Sci U S A 2014; 111: 9247-52. doi: 10.1073/pnas.1402196111
50. Hubbell JH, Seltzer SM. NIST physical reference data: X-Ray mass attenuation coefficients. Gaithersburg, MD: Radiation and Biomolecular Physics Division, PML, NIST; 1996.
51. Jain S, Coulter JA, Hounsell AR, Butterworth KT, McMahon SJ, Hyland WB, et al. Cellspecific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int J Radiat Oncol Biol Phys 2011; 79: 531-9. doi: 10.1016/j.ijrobp.2010.08.044
52. Porcel E, Liehn S, Remita H, Usami N, Kobayashi K, Furusawa Y, et al. Platinum nanoparticles: a promising material for future cancer therapy? Nanotechnology 2010; 21: 85103. doi: 10.1088/0957-4484/21/8/085103
53. McMahon SJ, Hyland WB, Muir MF, Coulter JA, Jain S, Butterworth KT, et al. Nanodosimetriceffects of gold nanoparticles inmegavoltage radiation therapy. RadiotherOncol 2011; 100: 412-16. doi: 10.1016/j.radonc.2011.08.026
54. Hainfeld JF, Dilmanian FA, Zhong Z, SlatkinDN, Kalef-Ezra JA, Smilowitz H. Goldnanoparticles enhance the radiation therapyof a murine squamous cell carcinoma. Phys Med Biol 2010; 55: 3045-59. doi: 10.1088/0031-9155/55/11/004
55. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006; 79: 248-53. doi: 10.1259/bjr/13169882
56. Mowat P, Mignot A, Rima W, Lux F, Tillement O, Roulin C, et al. In vitro radiosensitizing effects of ultrasmall gadolinium based particles on tumour cells. J Nanosci Nanotechnol 2011; 11: 7833-9.
57. Miladi I, Aloy M-T, Armandy E, Mowat P, Kryza D, Magné N, et al. Combining gadolinium-based nanoparticles with photon irradiation overcomes radioresistance of head and neck squamous cell carcinoma. Nanomedicine 2014; S1549-9634. doi: 10.1016/j.nano.2014.06.2013
58. Luchette M, Korideck H, Makrigiorgos M,Tillement O, Berbeco R. Radiation dose enhancement of gadolinium-based AGuIX nanoparticles on HeLa cells. Nanomedicine 2014; S1549-9634(14)00317-7. doi: 10.1016/j.nano.2014.06.004.
59. Porcel E, Tillement O, Lux F, Mowat P, Usami N, Kobayashi K, et al. Gadolinium-based nanoparticles to improve the hadrontherapy performances. Nanomedicine 2014; S1549-9634 (14)00218-4. doi: 10.1016/j.nano.2014.05.005.